Opc Expression, LPS Immunotype Switch and Pilin Conversion Contribute to Serum Resistance of Unencapsulated Meningococci

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Hubert, Kerstin ^a   Pawlik, Marie Christin ^a   Claus, Heike ^a   Jarva, Hanna ^b   Meri, Seppo ^b   Vogel, Ulrich ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; LIPOPOLYSACCHARIDE; OUTER MEMBRANE PROTEIN; PILIN; PROTEIN MUTS; VITRONECTIN;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM COLONY; BACTERIUM ISOLATE; BACTERIUM PILUS; BIOTRANSFORMATION; BLOOD ANALYSIS; CARBOXY TERMINAL SEQUENCE; CELL AGGREGATION; COLORIMETRY; COMPLEMENT INHIBITION; CONTROLLED STUDY; DNA REPAIR; ENVIRONMENTAL STRESS; EVOLUTIONARY ADAPTATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE SWITCHING; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; IGTA GENE; IGTC GENE; IMMUNOPHENOTYPING; MOLECULAR CLONING; MUTATIONAL ANALYSIS; NEISSERIA MENINGITIDIS; NONHUMAN; OPC GENE; PHYSICAL RESISTANCE; PILE GENE; PROTEIN BINDING; SCREENING TEST; SERUM BACTERICIDAL ACTIVITY; SIALYLATION; TRANSGENIC ORGANISM;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; BACTERIAL OUTER MEMBRANE PROTEINS; COLORIMETRY; COMPLEMENT SYSTEM PROTEINS; FIMBRIAE PROTEINS; FLOW CYTOMETRY; HUMANS; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; MUTATION; NEISSERIA MENINGITIDIS; SEQUENCE ANALYSIS, PROTEIN; SERUM; SERUM BACTERICIDAL ANTIBODY ASSAY;

BACTERIA (MICROORGANISMS); NEISSERIA MENINGITIDIS;

EID: 84866653363     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045132     Document Type: Article

References (71)

1. Schneider MC, Exley RM, Ram S, Sim RB, Tang CM, (2007) Interactions between Neisseria meningitidis and the complement system. Trends Microbiol 15: 233-240.
2. Vogel U, Weinberger A, Frank R, Muller A, Kohl J, et al. (1997) Complement factor C3 deposition and serum resistance in isogenic capsule and LOS sialic acid mutants of serogroup B Neisseria meningitidis. Infect Immun 65: 4022-4029.
3. Vogel U, Claus H, von Muller L, Bunjes D, Elias J, et al. (2004) Bacteremia in an immunocompromised patient caused by a commensal Neisseria meningitidis strain harboring the capsule null locus (cnl). J Clin Microbiol 42: 2898-2901.
4. Rappuoli R, (2000) Reverse vaccinology. Curr Opin Microbiol 3: 445-450.
5. Masignani V, Comanducci M, Giuliani MM, Bambini S, du-Bobie J, et al. (2003) Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med 197: 789-799.
6. Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, et al. (2010) Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A 107: 3770-3775.
7. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, et al. (2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177: 501-510.
8. Lewis LA, Ngampasutadol J, Wallace R, Reid JE, Vogel U, et al. (2010) The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog 6: e1001027.
9. Sa E, Cunha C, Griffiths NJ, Virji M, (2010) Neisseria meningitidis Opc invasin binds to the sulphated tyrosines of activated vitronectin to attach to and invade human brain endothelial cells. PLoS Pathog 6: e1000911 10.1371/journal.ppat.1000911 [doi].
10. Singh B, Jalalvand F, Morgelin M, Zipfel P, Blom AM, et al. (2011) Haemophilus influenzae protein E recognizes the C-terminal domain of vitronectin and modulates the membrane attack complex. Mol Microbiol 81: 80-98.
11. Griffiths NJ, Hill DJ, Borodina E, Sessions RB, Devos NI, et al. (2011) Meningococcal surface fibril (Msf) binds to activated vitronectin and inhibits the terminal complement pathway to increase serum resistance. Mol Microbiol 82: 1129-1149.
12. Geoffroy MC, Floquet S, Metais A, Nassif X, Pelicic V, (2003) Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis. Genome Res 13: 391-398.
13. Sun YH, Bakshi S, Chalmers R, Tang CM, (2000) Functional genomics of Neisseria meningitidis pathogenesis. Nat Med 6: 1269-1273 10.1038/81380 [doi].
14. Rodriguez T, Lastre M, Cedre B, Fajardo EM, del Campo J, et al. (2003) Validation of colorimetric assay to detect complement-mediated antibody-dependent bactericidal activity against serogroups B and C Neisseria meningitidis. Biologicals 31: 209-212.
15. Rodriguez T, Lastre M, Cedre B, del Campo J, Bracho G, et al. (2002) Standardization of Neisseria meningitidis serogroup B colorimetric serum bactericidal assay. Clin Diagn Lab Immunol 9: 109-114.
16. Richardson AR, Stojiljkovic I, (2001) Mismatch repair and the regulation of phase variation in Neisseria meningitidis. Mol Microbiol 40: 645-655.
17. Saunders NJ, Jeffries AC, Peden JF, Hood DW, Tettelin H, et al. (2000) Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58. Mol Microbiol 37: 207-215.
18. Martin P, van de Ven V, Mouchel N, Jeffries AC, Hood DW, et al. (2003) Experimentally revised repertoire of putative contingency loci in Neisseria meningitidis strain MC58: evidence for a novel mechanism of phase variation. Mol Microbiol 50: 245-257 3678 [pii].
19. Caugant DA, Bol P, Hoiby EA, Zanen HC, Froholm LO, (1990) Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986. J Infect Dis 162: 867-874.
20. Baker MG, Martin DR, Kieft CE, Lennon D, (2001) A 10-year serogroup B meningococcal disease epidemic in New Zealand: descriptive epidemiology, 1991-2000. J Paediatr Child Health 37: S13-S19.
21. Elias J, Schouls LM, van de Pol I, Keijzers WC, Martin DR, et al. (2010) Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany. Emerg Infect Dis 16: 465-472.
22. Joseph B, Schwarz RF, Linke B, Blom J, Becker A, et al. (2011) Virulence evolution of the human pathogen Neisseria meningitidis by recombination in the core and accessory genome. PLoS ONE 6: e18441.
23. Oster P, Lennon D, O'Hallahan J, Mulholland K, Reid S, et al. (2005) MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. Vaccine 23: 2191-2196.
24. Sarkari J, Pandit N, Moxon ER, Achtman M, (1994) Variable expression of the Opc outer membrane protein in Neisseria meningitidis is caused by size variation of a promoter containing poly-cytidine. Mol Microbiol 13: 207-217.
25. Hallstrom T, Trajkovska E, Forsgren A, Riesbeck K, (2006) Haemophilus influenzae surface fibrils contribute to serum resistance by interacting with vitronectin. J Immunol 177: 430-436.
26. Jennings MP, Srikhanta YN, Moxon ER, Kramer M, Poolman JT, et al. (1999) The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis. Microbiology 145 (Pt 11): 3013-3021.
27. Berrington AW, Tan YC, Srikhanta Y, Kuipers B, van der Ley P, et al. (2002) Phase variation in meningococcal lipooligosaccharide biosynthesis genes. FEMS Immunol Med Microbiol 34: 267-275.
28. Claus H, Maiden MC, Wilson DJ, McCarthy ND, Jolley KA, et al. (2005) Genetic analysis of meningococci carried by children and young adults. J Infect Dis 191: 1263-1271.
29. Virji M, Heckels JE, Potts WJ, Hart CA, Saunders JR, (1989) Identification of epitopes recognized by monoclonal antibodies SM1 and SM2 which react with all pili of Neisseria gonorrhoeae but which differentiate between two structural classes of pili expressed by Neisseria meningitidis and the distribution of their encoding sequences in the genomes of Neisseria spp. J Gen Microbiol 135: 3239-3251.
30. Meyer TF, Billyard E, Haas R, Storzbach S, So M, (1984) Pilus genes of Neisseria gonorrheae: chromosomal organization and DNA sequence. Proc Natl Acad Sci U S A 81: 6110-6114.
31. Swanson J, Bergstrom S, Robbins K, Barrera O, Corwin D, et al. (1986) Gene conversion involving the pilin structural gene correlates with pilus+ in equilibrium with pilus- changes in Neisseria gonorrhoeae. Cell 47: 267-276.
32. Marceau M, Beretti JL, Nassif X, (1995) High adhesiveness of encapsulated Neisseria meningitidis to epithelial cells is associated with the formation of bundles of pili. Mol Microbiol 17: 855-863.
33. Jennings MP, Virji M, Evans D, Foster V, Srikhanta YN, et al. (1998) Identification of a novel gene involved in pilin glycosylation in Neisseria meningitidis. Mol Microbiol 29: 975-984.
34. Power PM, Roddam LF, Rutter K, Fitzpatrick SZ, Srikhanta YN, et al. (2003) Genetic characterization of pilin glycosylation and phase variation in Neisseria meningitidis. Mol Microbiol 49: 833-847.
35. Borud B, Viburiene R, Hartley MD, Paulsen BS, Egge-Jacobsen W, et al. (2011) Genetic and molecular analyses reveal an evolutionary trajectory for glycan synthesis in a bacterial protein glycosylation system. Proc Natl Acad Sci U S A 108: 9643-9648.
36. Haas R, Schwarz H, Meyer TF, (1987) Release of soluble pilin antigen coupled with gene conversion in Neisseria gonorrhoeae. Proc Natl Acad Sci U S A 84: 9079-9083.
37. Bayliss CD, Hoe JC, Makepeace K, Martin P, Hood DW, et al. (2008) Neisseria meningitidis escape from the bactericidal activity of a monoclonal antibody is mediated by phase variation of lgtG and enhanced by a mutator phenotype. Infect Immun 76: 5038-5048.
38. Richardson AR, Yu Z, Popovic T, Stojiljkovic I, (2002) Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A 99: 6103-6107.
39. Zhu P, Klutch MJ, Bash MC, Tsang RS, Ng LK, et al. (2002) Genetic diversity of three lgt loci for biosynthesis of lipooligosaccharide (LOS) in Neisseria species. Microbiology 148: 1833-1844.
40. Zhu P, Morelli G, Achtman M, (1999) The opcA and (psi)opcB regions in Neisseria: genes, pseudogenes, deletions, insertion elements and DNA islands. Mol Microbiol 33: 635-650.
41. Keiser PB, Biggs-Cicatelli S, Moran EE, Schmiel DH, Pinto VB, et al. (2011) A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression. Vaccine 29: 1413-1420.
42. Singh B, Su YC, Riesbeck K, (2010) Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol Microbiol 78: 545-560.
43. Singh B, Blom AM, Unal C, Nilson B, Morgelin M, et al. (2010) Vitronectin binds to the head region of Moraxella catarrhalis ubiquitous surface protein A2 and confers complement-inhibitory activity. Mol Microbiol 75: 1426-1444.
44. Schmiel DH, Moran EE, Keiser PB, Brandt BL, Zollinger WD, (2011) Importance of Antibodies to Lipopolysaccharide in Natural and Vaccine-Induced Serum Bactericidal Activity against Neisseria meningitidis Group B. Infect Immun 79: 4146-4156 IAI.05125-11 [pii];10.1128/IAI.05125-11 [doi].
45. Ram S, Sharma AK, Simpson SD, Gulati S, McQuillen DP, et al. (1998) A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med 187: 743-752.
46. Wakarchuk WW, Gilbert M, Martin A, Wu Y, Brisson JR, et al. (1998) Structure of an alpha-2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1. Eur J Biochem 254: 626-633.
47. Jones DM, Borrow R, Fox AJ, Gray S, Cartwright KA, et al. (1992) The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb Pathog 13: 219-224.
48. Rytkonen A, Albiger B, Hansson-Palo P, Kallstrom H, Olcen P, et al. (2004) Neisseria meningitidis undergoes PilC phase variation and PilE sequence variation during invasive disease. J Infect Dis 189: 402-409.
49. Criss AK, Bonney KM, Chang RA, Duffin PM, LeCuyer BE, et al. (2010) Mismatch correction modulates mutation frequency and pilus phase and antigenic variation in Neisseria gonorrhoeae. J Bacteriol 192: 316-325.
50. Hagblom P, Segal E, Billyard E, So M, (1985) Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae. Nature 315: 156-158.
51. Craig L, Volkmann N, Arvai AS, Pique ME, Yeager M, et al. (2006) Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions. Mol Cell 23: 651-662.
52. Parge HE, Forest KT, Hickey MJ, Christensen DA, Getzoff ED, et al. (1995) Structure of the fibre-forming protein pilin at 2.6 A resolution. Nature 378: 32-38.
53. Blom AM, Rytkonen A, Vasquez P, Lindahl G, Dahlback B, et al. (2001) A novel interaction between type IV pili of Neisseria gonorrhoeae and the human complement regulator C4B-binding protein. J Immunol 166: 6764-6770.
54. Kahler CM, Martin LE, Tzeng YL, Miller YK, Sharkey K, et al. (2001) Polymorphisms in pilin glycosylation Locus of Neisseria meningitidis expressing class II pili. Infect Immun 69: 3597-3604.
55. Chamot-Rooke J, Mikaty G, Malosse C, Soyer M, Dumont A, et al. (2011) Posttranslational modification of pili upon cell contact triggers N. meningitidis dissemination. Science 331: 778-782.
56. Helaine S, Carbonnelle E, Prouvensier L, Beretti JL, Nassif X, et al. (2005) PilX, a pilus-associated protein essential for bacterial aggregation, is a key to pilus-facilitated attachment of Neisseria meningitidis to human cells. Mol Microbiol 55: 65-77.
57. Lappann M, Haagensen JA, Claus H, Vogel U, Molin S, (2006) Meningococcal biofilm formation: structure, development and phenotypes in a standardized continuous flow system. Mol Microbiol 62: 1292-1309.
58. Chiang SL, Taylor RK, Koomey M, Mekalanos JJ, (1995) Single amino acid substitutions in the N-terminus of Vibrio cholerae TcpA affect colonization, autoagglutination, and serum resistance. Mol Microbiol 17: 1133-1142.
59. Weiser JN, Pan N, McGowan KL, Musher D, Martin A, et al. (1998) Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med 187: 631-640.
60. Volanakis JE, (2001) Human C-reactive protein: expression, structure, and function. Mol Immunol 38: 189-197.
61. Casey R, Newcombe J, McFadden J, Bodman-Smith KB, (2008) The acute-phase reactant C-reactive protein binds to phosphorylcholine-expressing Neisseria meningitidis and increases uptake by human phagocytes. Infect Immun 76: 1298-1304.
62. Vogel U, Claus H, Heinze G, Frosch M, (1997) Functional characterization of an isogenic meningococcal α-2,3- sialyltransferase mutant: the role of lipooligosaccharide for serum resistance in serogroup B meningococci. Med Microbiol Immunol Berl 186: 159-166.
63. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, et al. (2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177: 501-510.
64. Unkmeir A, Latsch K, Dietrich G, Wintermeyer E, Schinke B, et al. (2002) Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol Microbiol 46: 933-946.
65. Ram S, Cox AD, Wright JC, Vogel U, Getzlaff S, et al. (2003) Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity. J Biol Chem 278: 50853-50862.
66. Merker P, Tommassen J, Kusecek B, Virji M, Sesardic D, et al. (1997) Two-dimensional structure of the Opc invasin from Neisseria meningitidis. Mol Microbiol 23: 281-293.
67. Scholten RJ, Poolman JT, Valkenburg HA, Bijlmer HA, Dankert J, et al. (1994) Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990. J Infect Dis 169: 673-676.
68. Apicella MA, Griffiss JM, Schneider H, (1994) Isolation and characterization of lipopolysaccharides, lipooligosaccharides, and lipid A. Methods Enzymol 235: 242-252.
69. Zollinger WD, Mandrell RE, (1977) Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay. Infect Immun 18: 424-433.
70. Dunn KL, Virji M, Moxon ER, (1995) Investigations into the molecular basis of meningococcal toxicity for human endothelial and epithelial cells: the synergistic effect of LPS and pili. Microb Pathog 18: 81-96.
71. Kurzai O, Schmitt C, Claus H, Vogel U, Frosch M, et al. (2005) Carbohydrate composition of meningococcal lipopolysaccharide modulates the interaction of Neisseria meningitidis with human dendritic cells. Cell Microbiol 7: 1319-1334.